Diavein Conference Cocktail

Diavein is a start-up developing and marketing an electro-stimulation device of the vascular system. Diavein aims to relieve the sickle cell disease, the most common orphan genetic disease in the world (5 million people affected). It is characterized in particular by vaso-occlusive crises, due to obstructions of the blood vessels, very painful and too often fatal.

Access to documents